HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Hereditary spastic paraplegia — Clinical Guidelines

Overview

Hereditary spastic paraplegia (HSP) is a group of genetic disorders characterized by progressive weakness and spasticity of the lower limbs due to dysfunction of the corticospinal tracts. 2

Diagnosis

Clinical Presentation: Spastic gait, lower limb weakness, and hyperreflexia 2.

Imaging: MRI often shows thinning of the corpus callosum (TCC), brain atrophy, and increased periventricular white matter signal intensity 2.

Genetic Testing: Screening for mutations in genes like SPG11 and SPG15, particularly in cases with TCC and central retinal degeneration 2.

Ophthalmological Evaluation: Essential for identifying central retinal degeneration, indicative of Kjellin syndrome 2.

Management

No Specific Pharmacological Treatment Mentioned: Current evidence does not specify first-line pharmacological treatments 1 2 3.

Supportive Therapies: Physical therapy to maintain mobility and prevent contractures 1.

Management of Comorbidities: Addressing conditions like Evans's syndrome, which may require immunosuppressive therapy 3.

Special Populations

Comorbidities: Rapid functional decline in patients with HSP and Evans's syndrome necessitates close monitoring and management of immune-related complications 3.

Key Recommendations

Genetic Testing for SPG11 and SPG15 Mutations in patients with hereditary spastic paraplegia and thin corpus callosum for accurate diagnosis (Evidence: Moderate) 2.

Comprehensive Neuroimaging including MRI to assess brain atrophy and white matter changes (Evidence: Moderate) 2.

Regular Ophthalmological Assessments in suspected Kjellin syndrome cases to detect central retinal degeneration (Evidence: Weak) 2.

Close Monitoring and Supportive Care for patients with comorbid Evans's syndrome to manage immune-related exacerbations (Evidence: Expert opinion) 3.

References

1 Palwa AR, Shafique M, Haqnawaz K. Hereditary Spastic<br /> Paraplegia: Role of MRI. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2021. link 2 Orlén H, Melberg A, Raininko R, Kumlien E, Entesarian M, Söderberg P et al.. SPG11 mutations cause Kjellin syndrome, a hereditary spastic paraplegia with thin corpus callosum and central retinal degeneration. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2009. link 3 Ahmed FE, Qureshi IM, Wooldridge MA, Pejaver RK. Hereditary spastic paraplegia and Evans's syndrome. Acta paediatrica (Oslo, Norway : 1992) 1996. link

Hereditary spastic paraplegia